Skip to main content
AAN.com

Abstract

Here we put forward a roadmap that summarizes important questions that need to be answered to determine more effective and safer treatments. A key concept in management of neurocysticercosis is the understanding that infection and disease due to neurocysticercosis are variable and thus different clinical approaches and treatments are required. Despite recent advances, treatments remain either suboptimal or based on poorly controlled or anecdotal experience. A better understanding of basic pathophysiologic mechanisms including parasite survival and evolution, nature of the inflammatory response, and the genesis of seizures, epilepsy, and mechanisms of anthelmintic action should lead to improved therapies.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (nash.pdf)

References

1.
Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol 2005;4:653–661.
2.
Commission on Tropical Diseases of the International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy. Epilepsia 1994;35:89–93.
3.
White AC, Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24:101–114.
4.
Nash TE. Human case management and treatment of cysticercosis. Acta Trop 2003;87:61–69.
5.
Sotelo J, del Brutto OH, Penagos P, Escobedo F, Torres B, Rodriguez-Carbajal J, et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol 1990;237:69–72.
6.
Carpio A, Santillan F, Leon P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995;155:1982–1988.
7.
Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004;350:249–258.
8.
Alarcon F, Dueñas G, Diaz M, Cevallos N, Estrada G. Short course of albendazole therapy for neurocysticercosis: a prospective randomized trial comparing three days, eight days and the control group without albendazole. Rev Ecuat Neurol 2001;10:1–6.
9.
Sotelo J, Penagos P, Escobedo F, Del Brutto OH. Short course of albendazole therapy for neurocysticercosis. Arch Neurol 1988;45:1130–1133.
10.
Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop 2003;87:71–78.
11.
Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389–392.
12.
Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696–701.
13.
Spina-Franca A, Nobrega JP, Livramento JA, Machado LR. Administration of praziquantel in neurocysticercosis. Tropenmed Parasitol 1982;33:1–4.
14.
Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43–51.
15.
Baranwal AK, Singhi PD, Singhi SC, Khandelwal N. Seizure recurrence in children with focal seizures and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up. J Child Neurol 2001;16:443–445.
16.
Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004;62:2236–2240.
17.
Pradhan S, Kathuria MK, Gupta RK. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol 2000;48:181–187.
18.
Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 2004;19:323–327.
19.
Flisser A, Correa D, Evans CAW. Taenia solium cysticercosis: new and revisited immunological aspects. In: Singh G, Prabhakar S, eds. Taenia solium cysticercosis. From basic to clinical science. Oxon: CABI Publishing, 2002:15–24.
20.
White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol 1997;66:209–230.
21.
Baig S, Damian RT, Morales-Montor J, Olecki P, et al. Characterization of excretory/secretory endopeptidase and metallo-aminopeptidases from Taenia crassiceps metacestodes. J Parasitol 2005;91:983–987.
22.
Robinson P, White AC, Lewis DE, Thornby J, David E, Weinstock J. Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infect Immun 2002;70:4534–4538.
23.
Stringer JL, Marks LM, White AC Jr, Robinson P. Epileptogenic activity of granulomas associated with murine cysticercosis. Exp Neurol 2003;183:532–536.
24.
Gonzales AE, Garcia HH, Gilman RH, Gavidia CM, Tsang VC, Bernal T, et al. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am J Trop Med Hyg 1996;54:391–394.
25.
Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: understanding a controversy. Acta Neurol Scand 1991;84:465–470.
26.
Rajshekhar V. Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. Neurology 1993;43:1238–1240.
27.
Chandy MJ, Rajshekhar V, Ghosh S, Prakash S, Joseph T, Abraham J, et al. Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry 1991;54:702–705.
28.
Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH, Marfil A, Onofre J. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases. J Neurol Sci 1995;130:25–34.
29.
Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR Am J Neuroradiol 1986;7:235–242.
30.
Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998;17:696–700.
31.
Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003;97:416–421.
32.
Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994;44:1344–1346.
33.
Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: a randomized controlled trial. J Pediatr 2003;143:111–114.
34.
Garg RK, Potluri N, Kar AM, et al. Short course of prednisolone in patients with solitary cysticercus granuloma: a double blind placebo controlled study. J Infect 2005.53:65–69
35.
Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 2003;44:1397–1401.
36.
Cruz ME, Schantz PM, Cruz I, Espinosa P, Preux PM, Cruz A, et al. Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol 1999;28:799–803.
37.
Garcia-Noval J, Allan JC, Fletes C, Moreno E, DeMata F, Torres-Alvarez R, et al. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. Am J Trop Med Hyg 1996;55:282–289.
38.
Medina MT, Duron RM, Martinez L, et al. Prevalence, incidence, and etiology of epilepsies in rural Honduras: the Salama Study. Epilepsia 2005;46:124–131.
39.
Sanchez AL, Lindback J, Schantz PM, et al. A population-based, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 1999;93:247–258.
40.
Del Brutto OH, Santibanez R, Idrovo L, et al. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 2005;46:583–587.
41.
Montano SM, Villaran MV, Ylquimiche L, et al. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 2005;65:229–233.
42.
Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004;62:1934–1938.
43.
Nash TE, Patronas NJ. Edema associated with calcified lesions in neurocysticercosis. Neurology 1999;53:777–781.
44.
Nash TE, Pretell J, Garcia HH. Calcified cysticerci provoke perilesional edema and seizures. Clin Infect Dis 2001;33:1649–1653.
45.
Sheth TN, Pillon L, Keystone J, Kucharczyk W. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR Am J Neuroradiol 1998;19:79–82.
46.
Loeb JA, Sohrab SA, Huq M, Fuerst DR. Brain calcifications induce neurological dysfunction that can be reversed by a bone drug. J Neurol Sci. 2006;243:77–81.
47.
Leite JP, Terra-Bustamante VC, Fernandes RM, et al. Calcified neurocysticercotic lesions and postsurgery seizure control in temporal lobe epilepsy. Neurology 2000;55:1485–1491.
48.
Wichert-Ana L, Velasco TR, Terra-Bustamante VC, et al. Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol 2004;61:1117–1119.
49.
Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry 1986;49:1131–1134.
50.
Proano JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 2001;345:879–885.
51.
Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg 1987;66:686–689.
52.
Bickerstaff ER, Cloake PCP, Hughes B, Smith WT. The racemose form of cerebral cysticercosis. Brain 1952;75:1–16.
53.
Takayanagui OM. Therapy for neurocysticercosis. Expert Rev Neurother 2004;4:129–139.
54.
Del Brutto OH. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients. J Neurol Neurosurg Psychiatry 1997;62:659–661.
55.
Estrada JJ, Kuhn RE. Immunochemical detection of antigens of larval Taenia solium and anti- larval antibodies in the cerebrospinal fluid of patients with neurocysticercosis. J Neurol Sci 1985;71:39–48.
56.
Correa D, Sandoval MA, Harrison LJ, et al. Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg 1989;83:814–816.
57.
Garcia HH, Harrison LJ, Parkhouse RM, et al. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1998;92:411–414.
58.
Fleury A, Hernandez M, Fragoso G, Parkhouse RM, Harrison LJ, Sciutto E. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg 2003;97:542–546.
59.
Zamora H, Castillo Y, Garcia HH, Pretall EJ, et al. Drop in antigen levels following successful treatment of subarachnoid neurocysticercosis. Am J Trop Med Hyg 2005;73:S41.
60.
Keiser PB, Nash TE. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent. Clin Infect Dis 2003;36:e122–e126.
61.
Proano JV, Madrazo I, Garcia L, Garcia-Torres E, Correa D. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg 1997;87:29–33.
62.
Anandh B, Mohanty A, Sampath S, Praharaj SS, Kolluri S. Endoscopic approach to intraventricular cysticercal lesions. Minim Invasive Neurosurg 2001;44:194–196.
63.
Bergsneider M, Holly LT, Lee JH, King WA, Frazee JG. Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 2000;92:14–23.
64.
Bergsneider M. Endoscopic removal of cysticercal cysts within the fourth ventricle. Technical note. J Neurosurg 1999;91:340–345.
65.
Cudlip SA, Wilkins PR, Marsh HT. Endoscopic removal of a third ventricular cysticercal cyst. Br J Neurosurg 1998;12:452–454.
66.
Seiffert E, Dreier JP, Ivens S, et al. Lasting blood–brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004;24:7829–7836.
67.
Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001;276:36734–36741.
68.
Beutler AS, Li S, Nicol R, Walsh MJ. Carbamazepine is an inhibitor of histone deacetylases. Life Sci 2005;76:3107–3115.

Information & Authors

Information

Published In

Neurology®
Volume 67Number 7October 10, 2006
Pages: 1120-1127
PubMed: 17030744

Publication History

Published online: October 9, 2006
Published in print: October 10, 2006

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

T. E. Nash, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
G. Singh, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
A. C. White, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
V. Rajshekhar, MCh
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
J. A. Loeb, MD, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
J. V. Proaño, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
O. M. Takayanagui, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
A. E. Gonzalez, DVM, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
J. A. Butman, MD, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
C. DeGiorgio, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
O. H. Del Brutto, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
A. Delgado-Escueta, MD, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
C.A.W. Evans, MD, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
R. H. Gilman, MD, DTMH
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
S. M. Martinez, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
M. T. Medina, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
E. J. Pretell, MD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
J. Teale, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.
H. H. Garcia, MD, PhD
From the Laboratory of Parasitic Diseases (T.E.N.), National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; Dayanand Medical College and Hospital (G.S.), Ludhiana, Punjab, India; Infectious Disease Section (A.C.W.), Department of Medicine, Baylor College of Medicine, Houston, TX; Department of Neurological Sciences (V.R.), Christian Medical College and Hospital, Vellore, India; Department of Neurology and Center for Molecular Medicine and Genetics (J.A.L.), Wayne State University School of Medicine, Detroit, MI; Medical Research Unit for Neurologic Diseases (J.V.P.), Hospital de Especialidades, Centro Medico Nacional Siglo XXI, Mexican Institute of Social Security, Mexico City; Department of Neurology (O.M.T.), School of Medicine of Ribeirao Preto, Universidade de Sao Paulo, Ribeirão Preto, Brazil; School of Veterinary Medicine (A.E.G.), Universidad Nacional Mayor de San Marcos, Lima, Perú; Department of International Health (A.E.G., R.H.G., H.H.G.), Johns Hopkins University Bloomberg School of Hygiene and Public Health, Baltimore, MD; Diagnostic Radiology Department (J.A.B.), Warren G. Magnuson Clinical Center, NIH, Bethesda, MD; Department of Neurology (C.D.G., A.D.-E.), Reed Neurological Research Center, UCLA, Los Angeles, CA; Department of Neurological Sciences (O.H.D.B.), Hospital-Clínica Kennedy, Guayaquil, Ecuador; VA Epilepsy Center of Excellence (A.D.-E.), Los Angeles, CA; University of Cambridge Clinical School (C.A.W.E.), Cambridge, and Department of Infectious Diseases and Microbiology, Imperial College London, London, UK; Department of Microbiology (R.H.G., E.J.P., H.H.G.), Universidad Peruana Cayetano Heredia, Lima, Perú; Cysticercosis Unit (S.M.M., H.H.G.), Instituto Especializado en Ciencias Neurológicas, Lima, Peru; Universidad Nacional Autonoma de Honduras (M.T.M.), Tegucigalpa, Honduras; and Department of Microbiology and Immunology (J.T.), University of Texas Health Science Center, San Antonio.

Notes

Address correspondence and reprint requests to Dr Nash, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD; e-mail: [email protected]

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Neurocysticercosis: A Review on Global Neurological Disease, Taeniasis and Cycticercosis/Neurocysticercosis - Global Epidemiology, Pathogenesis, Diagnosis, and Management, (2024).https://doi.org/10.5772/intechopen.110627
    Crossref
  2. Advancement in the Identification of Parasites and Obstacles in the Treatment of Intestinal Parasitic Infections: A Brief Overview, Intestinal Parasites  - New Developments in Diagnosis, Treatment, Prevention and Future Directions, (2024).https://doi.org/10.5772/intechopen.1005455
    Crossref
  3. Surgical management of intraventricular neurocysticercosis: Two cases treated through transcallosal interhemispheric approach, Surgical Neurology International, 15, (193), (2024).https://doi.org/10.25259/SNI_301_2024
    Crossref
  4. Preferred Therapy for Specific Parasitic Pathogens, 2024 Nelson’s Pediatric Antimicrobial Therapy, (2024).https://doi.org/10.1542/9781610026970-ch9
    Crossref
  5. An overview on helminthic infections of central nervous system in humans, A Review on Diverse Neurological Disorders, (43-72), (2024).https://doi.org/10.1016/B978-0-323-95735-9.00048-6
    Crossref
  6. Recent Trends in Neurocysticerosis Diagnosis and Management, Rising Contagious Diseases, (337-350), (2024).https://doi.org/10.1002/9781394188741.ch24
    Crossref
  7. Advancement in Epilepsy Pharmacotherapy: An Insight into the Pharmacophoric Approaches of Recent Drugs, Central Nervous System Agents in Medicinal Chemistry, 23, 3, (145-156), (2023).https://doi.org/10.2174/1871524923666230822104733
    Crossref
  8. Preferred Therapy for Specific Parasitic Pathogens, 2023 Nelson’s Pediatric Antimicrobial Therapy, (2023).https://doi.org/10.1542/9781610026512-ch9
    Crossref
  9. Neurocysticercosis: Isolated Lesion in the Left Middle Frontal Gyrus, Archives of Clinical Neuropsychology, 39, 4, (528-534), (2023).https://doi.org/10.1093/arclin/acad090
    Crossref
  10. Update on the diagnosis and management of neurocysticercosis, Arquivos de Neuro-Psiquiatria, 80, 5 suppl 1, (296-306), (2022).https://doi.org/10.1590/0004-282x-anp-2022-s115
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share